Regeneron registers Phase 3 LINKER-AL1 trial of linvoseltamab for AL amyloidosisOct 30Weekly roundup, 6 itemscemiplimab-rwlcdupilumabUpdated
Regeneron registers Phase 1 REGN17235 trial and joins Maryland-led lung cancer studyAug 7Weekly roundup, 2 itemscemiplimab-rwlcRegeneron Pharmaceuticals